|
Volumn 353, Issue 6301, 2016, Pages 823-826
|
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection
a a b c d,e a a a a d d d d c c f g,h,i d j,k f more..
a
Humabs BioMed SA
*
(Switzerland)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHEMOKINE RECEPTOR CXCR3;
CROSS REACTING ANTIBODY;
GLYCOPROTEIN E1;
GLYCOPROTEIN E2;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY LALA;
NEUTRALIZING ANTIBODY;
NONSTRUCTURAL PROTEIN 1;
UNCLASSIFIED DRUG;
VIRUS ANTIBODY;
ZIKA VIRUS VACCINE;
EPITOPE;
VIRUS ENVELOPE PROTEIN;
VIRUS PROTEIN;
ANTIBODY;
CELLS AND CELL COMPONENTS;
HOMOLOGY;
HOST SPECIFICITY;
IMMUNE RESPONSE;
MEMORY;
PROTEIN;
PUBLIC HEALTH;
RODENT;
VIRAL DISEASE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIBODY ISOLATION;
ANTIBODY PRODUCTION;
ANTIBODY RESPONSE;
ANTIBODY SPECIFICITY;
ARTICLE;
CD4+ T LYMPHOCYTE;
CONTROLLED STUDY;
CROSS REACTION;
DENGUE;
DENGUE VIRUS 1;
DENGUE VIRUS 2;
DENGUE VIRUS 3;
DENGUE VIRUS 4;
DRUG POTENCY;
HUMAN;
HUMAN CELL;
INFECTION PREVENTION;
MEMORY T LYMPHOCYTE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SERODIAGNOSIS;
TH1 CELL;
VACCINATION;
VIRION;
VIRUS LOAD;
VIRUS NEUTRALIZATION;
WEIGHT REDUCTION;
ZIKA FEVER;
ZIKA VIRUS;
ANIMAL;
CHEMISTRY;
DENGUE VIRUS;
DISEASE MODEL;
IMMUNOLOGICAL MEMORY;
IMMUNOLOGY;
PREVENTION AND CONTROL;
PROTEIN TERTIARY STRUCTURE;
T LYMPHOCYTE;
THERAPY;
DENGUE VIRUS;
FLAVIVIRUS;
MUS;
ZIKA VIRUS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEUTRALIZING;
ANTIBODIES, VIRAL;
ANTIBODY SPECIFICITY;
CROSS REACTIONS;
DENGUE VIRUS;
DISEASE MODELS, ANIMAL;
HUMANS;
IMMUNODOMINANT EPITOPES;
IMMUNOLOGIC MEMORY;
PROTEIN STRUCTURE, TERTIARY;
T-LYMPHOCYTES;
VIRAL ENVELOPE PROTEINS;
VIRAL NONSTRUCTURAL PROTEINS;
ZIKA VIRUS;
ZIKA VIRUS INFECTION;
|
EID: 84978910758
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aaf8505 Document Type: Article |
Times cited : (642)
|
References (38)
|